chronic lymphocytic leukemia phenotype

Aliases

CLL

Related entities (2)

Mentioned in (36)

Papers in which this entity is mentioned.

• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
• Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Application of third-generation sequencing in cancer research. (2021)
• Detection and characterization of lung cancer using cell-free DNA fragmentomes. (2021)
• kataegis: an R package for identification and visualization of the genomic localized hypermutation regions using high-throughput sequencing. (2021)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
• The repertoire of mutational signatures in human cancer. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
• Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
• CALDER: Inferring Phylogenetic Trees from Longitudinal Tumor Samples. (2019)
• The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Tumor phylogeny inference using tree-constrained importance sampling. (2017)
• Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience. (2017)
• Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. (2016)
• BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. (2015)
• An atlas of active enhancers across human cell types and tissues. (2014)
• CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
• Clonal evolution in hematological malignancies and therapeutic implications. (2014)
• TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. (2014)
• Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
• Signatures of mutational processes in human cancer. (2013)
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. (2013)
• Mutational heterogeneity in cancer and the search for new cancer-associated genes. (2013)
• Thalidomide-a notorious sedative to a wonder anticancer drug. (2013)
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. (2013)
• Molecular genetics of B-precursor acute lymphoblastic leukemia. (2012)
• Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. (2012)
• Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
• Massive genomic rearrangement acquired in a single catastrophic event during cancer development. (2011)
• Teratogenic effects of thalidomide: molecular mechanisms. (2011)
• Copy-number-variation and copy-number-alteration region detection by cumulative plots. (2009)
• 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.